Tiens India Bio-Engineering And Marketing Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2017
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets %
About Tiens India Bio-Engineering And Marketing
Tiens India Bio-Engineering And Marketing Private Limited (TIBAMPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 30 July 2008 and has a history of 16 years and six months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Jayapal Chandrasekaran and Chao Zhang serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51101TN2008FTC068701
- Company No.
068701
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
30 Jul 2008
- Date of AGM
30 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Tiens India Bio-Engineering And Marketing?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayapal Chandrasekaran  | Director | 30-Jul-2008 | Current |
Chao Zhang  | Director | 25-Jul-2013 | Current |
Financial Performance of Tiens India Bio-Engineering And Marketing.
Tiens India Bio-Engineering And Marketing Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tiens India Bio-Engineering And Marketing?
In 2017, Tiens India Bio-Engineering And Marketing had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tiens India Bio-Engineering And Marketing?
Unlock and access historical data on people associated with Tiens India Bio-Engineering And Marketing, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tiens India Bio-Engineering And Marketing, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tiens India Bio-Engineering And Marketing's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
